Menu Search
Equities

Hygeia Healthcare Holdings Co Ltd

6078:HKG.HZ

Hygeia Healthcare Holdings Co Ltd

Actions
  • Price (HKD)37.45
  • Today's Change-1.60 / -4.10%
  • Shares traded5.42m
  • 1 Year change-27.77%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hygeia Healthcare Holdings Co Ltd is a China-based investment holding company principally involved in oncology medical business. Through its subsidiaries, the Company mainly operates three segments. The Hospital Business segment provides outpatient and inpatient services for patients through its own hospitals. The Radiotherapy Business segment provides radiotherapy center consulting services, as well as the leasing, sales, disposal, and post-sales repair and maintenance services of radiotherapy equipment. The Hospital Management Service segment provides management related services to other hospitals. The Company conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)4.41bn
  • Net income in HKD738.10m
  • Incorporated2018
  • Employees8.24k
  • Location
    Hygeia Healthcare Holdings Co LtdRoom 702-707, Enterprise SquareNo.228 Meiyuan Road, Jing'an DistrictSHANGHAI ChinaCHN
  • Websitehttp://www.hygeia-group.com.cn/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		6078:HKG since
announced		Transaction
value
Datang Healthcare Co LtdAnnounced25 Jul 202325 Jul 2023Announced-17.33%161.72m
Data delayed at least 15 minutes, as of May 17 2024 09:08 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.